419 related articles for article (PubMed ID: 16198295)
1. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
[TBL] [Abstract][Full Text] [Related]
2. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
Keah HH; Hearn MT
J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
[TBL] [Abstract][Full Text] [Related]
4. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the inhibition of activin signalling by follistatin.
Harrington AE; Morris-Triggs SA; Ruotolo BT; Robinson CV; Ohnuma S; Hyvönen M
EMBO J; 2006 Mar; 25(5):1035-45. PubMed ID: 16482217
[TBL] [Abstract][Full Text] [Related]
6. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
Greenwald J; Fischer WH; Vale WW; Choe S
Nat Struct Biol; 1999 Jan; 6(1):18-22. PubMed ID: 9886286
[TBL] [Abstract][Full Text] [Related]
7. Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG).
Arai KY; Tsuchida K; Li C; Watanabe G; Sugino H; Taya K; Nishiyama T
Protein Expr Purif; 2006 Sep; 49(1):78-82. PubMed ID: 16737827
[TBL] [Abstract][Full Text] [Related]
8. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.
Thompson TB; Woodruff TK; Jardetzky TS
EMBO J; 2003 Apr; 22(7):1555-66. PubMed ID: 12660162
[TBL] [Abstract][Full Text] [Related]
9. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII.
de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC
Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694
[TBL] [Abstract][Full Text] [Related]
10. Beta A versus beta B: is it merely a matter of expression?
Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver.
Ichikawa T; Zhang YQ; Kogure K; Hasegawa Y; Takagi H; Mori M; Kojima I
Hepatology; 2001 Nov; 34(5):918-25. PubMed ID: 11679962
[TBL] [Abstract][Full Text] [Related]
13. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
Arandjelovic S; Freed TA; Gonias SL
Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
[TBL] [Abstract][Full Text] [Related]
14. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
15. New insights into the mechanisms of activin action and inhibition.
Walton KL; Makanji Y; Harrison CA
Mol Cell Endocrinol; 2012 Aug; 359(1-2):2-12. PubMed ID: 21763751
[TBL] [Abstract][Full Text] [Related]
16. The regulation and functions of activin and follistatin in inflammation and immunity.
Hedger MP; Winnall WR; Phillips DJ; de Kretser DM
Vitam Horm; 2011; 85():255-97. PubMed ID: 21353885
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the existence of a local activin follistatin negative feedback loop in the goldfish pituitary and its regulation by activin and gonadal steroids.
Cheng GF; Yuen CW; Ge W
J Endocrinol; 2007 Dec; 195(3):373-84. PubMed ID: 18000300
[TBL] [Abstract][Full Text] [Related]
18. Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions.
Lerch TF; Shimasaki S; Woodruff TK; Jardetzky TS
J Biol Chem; 2007 May; 282(21):15930-9. PubMed ID: 17409095
[TBL] [Abstract][Full Text] [Related]
19. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
Mercado-Pimentel ME; Runyan RB
Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
[TBL] [Abstract][Full Text] [Related]
20. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding.
Mace PD; Cutfield JF; Cutfield SM
Biochem Biophys Res Commun; 2006 Dec; 351(4):831-8. PubMed ID: 17094948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
